[1]
“IL-23 Inhibitors in Psoriasis: A Canadian Dermatology Roundtable”, Can Dermatol Today, vol. 7, no. s03, pp. 2–9, Sep. 2026, doi: 10.58931/cdt.2026.7s03166.